A phase II, single-centre, randomised, single-blind, study to evaluate Vi-CRM197 against historical unvaccinated controls in a healthy adult challenge model, with a Vi-PS vaccine control arm.
Phase of Trial: Phase II
Latest Information Update: 10 Sep 2012
At a glance
- Drugs Typhoid vaccine Vi conjugate (Primary) ; Typhoid vaccine Vi-polysaccharide (Primary)
- Indications Typhoid
- Focus Therapeutic Use
- 10 Sep 2012 New trial record